XtalPi Holdings Limited (HKG:2228)

Hong Kong · Delayed Price · Currency is HKD

10.06

+0.33 (3.39%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Drug Discovery Solutions	103.66M	87.73M	87.67M	39.35M
Drug Discovery Solutions Growth	18.16%	0.07%	122.81%	-
Intelligent Robotics Solutions	162.77M	86.69M	45.69M	23.45M
Intelligent Robotics Solutions Growth	87.76%	89.75%	94.80%	-
Total	266.43M	174.42M	133.35M	62.80M
Total Growth	52.75%	30.80%	112.35%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	151.35M	95.53M	-	-
Mainland China Growth	58.43%	-	-	-
United States	79.89M	52.25M	25.82M	13.53M
United States Growth	52.91%	102.37%	90.88%	-
Other Regions	35.20M	26.65M	6.13M	3.51M
Other Regions Growth	32.10%	334.52%	74.95%	-
The People's Republic of China (PRC)	-	-	101.40M	45.77M
The People's Republic of China (PRC) Growth	-	-	121.56%	-
Total	266.43M	174.42M	133.35M	62.80M
Total Growth	52.75%	30.80%	112.35%	-

Source: S&P Global Market Intelligence.